Dr Reddy’s focuses on differentiated portfolio in key therapy areas for growth in India: GlobalData EP News Bureau Mar 24, 2023 DRL has earlier this month divested nine dermatology brands to Eris Lifesciences for Rs 2750 million ($33.3 million*). Within a…
